1. Metabolic Syndrome Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer
   Ying Lu et al, 2022, Frontiers in Oncology CrossRef
2. A Novel Oral Arginase 1/2 Inhibitor Enhances the Antitumor Effect of PD-1 Inhibition in Murine Experimental Gliomas by Altering the Immunosuppressive Environment
   Paulina Pilanc et al, 2021, Frontiers in Oncology CrossRef